Summary:
We are conducting a clinical research study testing the effectiveness of a new investigational medication for lupus and the associated rash.
Qualified Participants Must:
•
Be diagnosed with SLE with a moderate to severe, persistent rash
•
Be willing to undergo physical examination and blood tests to determine eligibility for the study
Qualified Participants May Receive:
Comprehensive evaluation of current lupus disease activity, compensation will be available for time and travel, and study related medication, care and medical testing at no cost.